Hussain Sajwani is the founder and Chairman of the luxury real estate development agency DAMAC Properties, located in Dubai. DAMAC has made an impressive statement in the real estate industry with their glamorous advertisement perks, including brand new Bentley’s with a new apartment buyer’s agreement! But, Hussain Sajwani has not always been in a glitzy billion dollar business position.
With humble beginnings in the food service industry, Hussain Sajwani worked to expand his revenue and reach a larger, more profitable clientele, going as far as working with the American military during Desert Storm. Hussain Sajwani felt that he needed a more profitable margin that he wouldn’t be able to accomplish in the food service industry.
He continued in food until 2001 when Dubai began to allow foreigners to own property. Since his entrance into real estate business, Hussain Sajwani has made immense strides towards success, including teaming with American President Donald Trump on new projects in Dubai.
For many years, DAMAC Owner Hussain Sajwani has had close business ties with Donald Trump and his real estate firm, The Trump Organization. DAMAC, along with the Trump family, have come together to develop two Trump-branded golf courses in Dubai.
Due to speculation by the American people, the Trump family, consisting of wife Ivanka, daughter and two sons, handle the majority of business transactions between the Trump Organization and DAMAC. Read more: Hussain Sajwani | Forbes and Hussain Sajwani | Twitter
While their relationship is not only business, DAMAC Owner Hussain Sajwani and his family have attended Trump functions such as their large New Year’s Eve party. Both billionaires share equal admiration for the work that the respective other has and is doing for the real estate industry.
DAMAC Owner Hussain Sajwani started in food service and has worked for years now to build his billion dollar real estate business.
With elaborate and extensive advertising, collaborating with large scale companies like Versace and having a business contact list the world could envy, Hussain Sajwani is a force to be reckoned with in the real estate industry of not only Dubai, but the world!
Mr. Randal Alan Nardone co-founded Fortress Investment Group LLC in 1998. He has held the position as its chief executive officer since August 2013. In 1998 he took on the role of principal in addition to his current responsibilities. Mr. Nardone serves in several senior management positions and on many boards as well. He also holds the title of Chief Executive Officer of Fortress Macro Advisors, LLC and Fortress Macro Falstaff Advisors.
Another one of his multiple roles and positions of responsibility is that of secretary and chief operating officer at Impac Commerical Holdings, Inc. He is also the principal at FM Falstaff Advisors and Fortress Investment Group LLC. He co-founded FM Falstaff Advisors LLC and performs the role of non-independent director at Fortress Investment Group LLC.
Before he co-founded Fortress in May 1997, Mr. Nardone was the managing director of the United Bank of Switzerland. Prior to that, he worked as the principal of BlackRock Financial Management, Inc. Before that, Randal Nardone was a partner and member of the executive committee of Thacher, Proffitt, & Wood, a law firm.
Other positions he holds are those as president and chairman of Springleaf Financial Holdings, LLC, and vice-president and secretary of Newcastle Investment Holdings LLC. Nardone was on the Forbes billionaire list until March of 2007, where he was ranked by the company as the 557th richest man in the world. This was the same year that Nardone purchased a condo at 101 Warren Street for $22 million. This Tribeca condo had square footage of 5,769 and is located actually above the penthouses.
In November of 2008, Mr. Nardone’s Fortress stock decreased significantly. It had gone public in early 2007. The share price dropped to a new 52-week low of $2.22 from a 52-week high of $19.50. Consequently, Mr. Nardone’s net worth was significantly decreased, and he was cut from the Forbes billionaires list.
Mr. Nardone has a degree in law, earning his J.D. from Boston University. He did his undergraduate studies at the University of Connecticut, where he earned a BA in English and BS in biology.
For More info: www.directorstats.co.uk/director/randal-nardone/
Many women in the modern society are doing exemplary well in the music industry. Many women are now leading some of the greatest organizations in the music industry. Female executives have also mushroomed in the recent past and have been in the forefront for fighting for key positions in the industry. They have been very instrumental in fighting for deals, promoting tastemakers in the industry and have provided great influence in the billboard top charts. One of such great women that are taking the industry by storm is Desire Perez.
Desire Perez has been the striking force behind the biggest hits in the top billboard music in the United States. She is a strong woman and has been working g for ages with the rock legend Jay Z. She is running the SC Enterprise which is a key entertainment industry in the States. Perez has been able to consolidate her position for many years because of her intense qualities and capabilities in the industry. Many sources privy to the organization have commended Perez for her outstanding qualities. They have acknowledged her as a tough and a unique negotiator.
It is for these rare skills that have seen Desire Perez maintaining a high relevance in the ever dynamic music industry. She has negotiated for many big deals in the music industry, and she has been recognized as one who led the negotiation in the Beyonce Formation Stadium and also was a key player in the Rihanna Samsung Deal. She is one of the key women running the Roc Nation, and she is the Chief Operating Officer. Roc Nation is one of the largest labeling, publishing and also a marketing platform for many great artists in the United States. Desire Perez has nevertheless made a rich and enterprising career in the music industry and has commanded a huge following and great respect for her critical roles.
In 2010 Jason Hope donated $500,000 to SENS Research Foundation to aid in the research of Rejuvenation Biotechnologies to combat age-related diseases. Jason is working with the Chief Science Officer of the foundation, Dr. Aubrey de Grey, since making that donation. Dr. de Grey has been concentrating on reversing the aging process by researching new treatment for diseases like Alzheimer’s, a neurodegenerative disease, as well as other age-related conditions such as Parkinson’s, heart disease and cancer.
Jason Hope has written articles for publications such as Medium and Tech.co. discussing such things as cell loss, waste disposal for cells as well as technology trends.
He sees a huge future in the Internet of Things where not only can you set your thermostat remotely or look in the your refrigerator from the grocery store to see what you need to pick but also where a connected kitchen and grocery stores can reduce food waste. And a future where urban centers have connected devices that allow them to be run more efficiently in the areas of the smart grid and traffic technology. But Jason insists security risks and bugs must be worked out before much of that can come to fruition.
On Jason Hope’s official website he chooses the most interesting business ideas submitted and grants money to the authors to jump start proposals believing that the future depends on these great ideas.
He is a member of the Director’s Circle at Teach for America and the Arizona Science Center as well as working with the Leukemia & Lymphoma Society’s Desert Mountain States Chapter, the Andre Agassi Foundation, the Mark Wahlberg Youth Foundation, Family Health International, the Boys & Girls Club of Metropolitan Phoenix and the TGen Foundation a non-profit institute that works toward turning genetic research into medical advances.
Jason Hope is an Arizona native and received a degree in finance from Arizona State University and then an MBA from Arizona State University’s W.P. Carey School of Business.
Expansion Therapeutics has recently raised 55.3 million dollars for the purpose of discovering a cure or new therapeutic techniques for myotonic dystrophy type 1 (DM1.)
The disease is caused when RNA levels in the body reach toxic levels and begin to damaging the body from the inside out. Expansion Therapeutics, along with Sanofi Ventures, Novartis Venture Fund, and Kleiner Perkins, in a best case scenario will discover a way to reduce levels of RNA in patients and cease the destruction to bones, organs and tissue. Read more: Scott Rocklage | Bloomberg and Scott Rocklage | Crunchbase
The disease is passed on genetically, so in rare cases entire families could be affected by DM1. A cure for the disease could not only save the lives of individuals but entire families could benefit from a cure.
All research is conducted at a laboratory owned by Matthew D. Disney. Dr. Disney believes that RNA disorders can be treated with small molecule medications. Dr. Disney says that his research will continue until progress is made towards combating diseases related to increased levels of RNA.
ABOUT SCOTT ROCKLAGE
Scott Rocklage received his bachelors degree in Chemistry from the University of California, Berkeley and his PhD in Chemistry at the Massachusetts Institute of Technology. With 30 years of experience in healthcare management, he is currently a Managing Partner of 5AM Ventures.
Rocklage is also Executive Director at Expansion Therapeutics. As a chemist is has invented or co-invented over 30 United States patents and has been published over 100 times. In 2005, Rocklage was awarded the Nobel Peace Prize in Chemistry.
Learn more about Scott Rocklage: https://www.linkedin.com/in/scott-rocklage-66aa7a12a and https://ideamensch.com/scott-rocklage/
PSI Pay is an UK-licensed payment solution institution that provides e-money services in the European Union. It is also the main Fin-tech company licensed by MasterCard to both issue debit and credit payment cards together with contactless programs and virtual cards across the European Economic Area (EAA).
This role makes the company responsible for reporting to the FCA on necessary information on the Master Cards activities that may include reporting, compliance, and audits.
Having begun its operations in the year 2007, PSI Pay has a global audience that terms them as transparent and effective. This has been supported by PSI’s professionals in the banking sector who are knowledgeable regarding alternative payments.
Among their variety of products, the MasterCard Contactless Card has also caught a lot of attention by allowing members to make payment of goods and services without having to enter a pin.By placing the card over a card reader you can make a payment of up to or less than £20.This method of transacting seems risky but each transaction is uniquely encrypted to protect transaction data and just in-case you happen to tap the card twice you can only bill once.
The company recently partnered with Kerv wearable to give the world the first ever contactless payment ring. This payment ring will be accessible in 38 million worldwide locations and will allow users to contribute to their accounts through their debit or credit cards and bank transfer or PayPal.
Kerv users will also have access to a virtual card that will allow online purchases. Commenting on the partnership, Managing Director Phil Davies was excited about their new partnership of creating a very new experience for their clients.
Providing Quality Services
Constantly aiming to provide the best services to their audience PSI Pay came in to assure their clientele that they will not be affected by any eventualities of the Brexit as the company had already planned on how they would remain stable.
Over the years striving to be the best service providers in the field has paid off really well. In the year 2015, the FinTech Company experienced it best financial period, PSI’s overall business revenue increased by 29 %. The growth in revenue was due to the launch of their affiliate program, expansion into other regions, various product launches and promotional campaigns.
To keep in touch with their audience PSI Pay has an updated Linkedin profile with details of their roles and objectives. Their company profile on the platform also gives more information details such as the number of employees and headquarters thus raising an interest to click on the link provided to redirect you to the company website for more information.
Communication has been an essential part of our daily lives in the 21st century. People would always need to connect online so that they can talk to their friends and family. There are also some applications which are designed to meet certain needs of an individual, just like Talkspace which allows someone to speak with their therapists using an app. Talkspace was designed so that people who are having issues with visiting a therapist can just talk to them online. Some people lack the confidence to speak with a real therapist, and they believe that by using Talkspace, they could be able to express what they have in mind without limiting themselves just because they are shy.
The number of Talkspace users around the world is constantly increasing. Some of those who have downloaded the application stated that they downloaded it because they do not have the time to visit their therapist, and it is very convenient to use. Time and money are also saved once the app is downloaded. On the therapist’s part, they stated that they would be downloaded the app because they know that their patients are getting better if they would be talking to them whatever platform is available. The app is similar to Snapchat, but it is somehow controversial because of how it is being used to speak with a therapist. Still, people are enjoying using it.
In Talkspace, people can send messages, photos, and audios to one another. Using Talkspace can ease the burden of speaking, and according to some therapists, some people effectively communicate using only photos, and they are fine with that. These people are having a hard time expressing and explaining themselves if they talk face to face, so using the app would help them describe how they feel. The therapists are also stating that it is vital for someone to respond to the messages that they are receiving because when they reply back to the sender, they somehow feel appreciated. This is good, according to the therapists, especially if someone is going to serious treatment and medication. Talkspace is the future of communication, and many people are starting to like it.
Cancer research has been experiencing a revolution in a sense. The industry has been producing many more powerful medications than in years of the past. These technologically advanced facilities are placed all around the world, but the United States is home to one of the leaders in this exclusive class. Located in Bothell, Washington, is Seattle Genetics, and it epitomizes the term revolutionary science. The biotech company has 20 years under its belt, and it has grown each and every year. CEO Clay Siegall is the captain of the ship, and he has at least 30 years of experience in the game.
Siegall is probably one of the most celebrated and accomplished professionals in cancer research. The guy has a resume that others dream about having, but he has always remained humble. Siegall is a published author, he has written up to 70 publications, and he holds well-over 15 patents. Yes, this guy is the real deal, but he isn’t completely satisfied with his success. In some form or fashion, everyone has seen cancer’s effects or has dealt with cancer in one way or another. Siegall has introduced some very strict rules and regulations for conducting business. When it comes to a person’s health, time is of the essence. Copious amounts of information is being recorded at a consistent rate and scientific innovation is the catalyst. When these two components are combined, great things are about to transpire.
Seattle Genetics has many distribution deals thanks to Siegall because he was able to secure multiple deals with top pharmaceutical companies. Pfizer and Bayer are just two of the high-profile names. The old-guard of cancer research has come full-circle, and it has saved many lives. Siegall uses every aspect of his educational background in Zoology and from Genetics. Cancer may not be totally eradicated, but’s has definitely seen better days, which is a good thing.
Dr. Clay Siegall is leading the new wave of targeted cancer therapies. Perhaps a few years from now we will be looking at the Seattle Genetics founder and CEO as a legend in cancer treatment. He officially co-founded the Seattle based biotech company in 1998. Since then it has become a leader in providing advanced anti-body conjugates for cancer treatment. The company’s immediate goal is to vastly improve the mortality rate of cancers that have seen no substantial improvements in decades.
Seattle Genetics is responsible for developing the first FDA-approved antibody drug conjugate. Even more impressive it has partnered with multiple drug manufacturers to roll out its impressive string of drugs. Its partners includes prominent manufacturers such as Bayer and Genentech.
When Dr. Clay first founded Seattle Genetics many professionals thought it wouldn’t make it past the startup phase. Although Dr. Clay and Seattle Genetics exceeded those expectations those who doubted all those years ago had reason. At the time it was just a tiny startup with a small team of researchers. Despite its humble beginnings Dr. Clay always had big plans for the company’s future. Seattle Genetics is continually expanding its list of drugs while simultaneously adding more to the development pipeline.
Dr. Clay founded came up with the idea to start Seattle Genetics after a family member was diagnosed with cancer and he was unsatisfied with the chemotherapy treatment. Because of this it is his belief that systematic chemotherapy is soon to be outdated and targeted therapies are the future.
Before founding Seattle Genetics Dr. Clay Siegall he worked as a researcher at various medical organizations. he worked at the National Cancer Institute for 3 years before departing and joining Bristol-Myers Squibb Pharmaceutical Research Institute.
He graduated from the University of Maryland with a B.S. in zoology and George Washington University where he studied genetics.
Dr. Clay has also been recognized for his excellent work several times, being awarded the Pacific Northwest Ernst & Young Entrepreneur of the Year in 2012.